Overview

A class action lawsuit has been filed against Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC) and certain of the Company’s current and former senior executive officers alleging violations of the federal securities laws.  The Teladoc lawsuit is brought on behalf of all persons and entities who purchased or otherwise acquired Teladoc stock between November 2, 2022, and February 20, 2024, both dates inclusive (the “Class Period”).  Investors have until July 16, 2024, to seek appointment as lead plaintiff of the Teladoc class action lawsuit.

Teladoc provides virtual healthcare services.  The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp.

The Teladoc lawsuit alleges that Defendants knew that the adverse facts specified below had not been disclosed and were being concealed from the public and that the positive representations being made were materially false and misleading.  Specifically, Defendants failed to disclose that: (1) the Company continued to expand its marketing spend throughout 2023, despite public assurances that it would pull back its advertising spending; (2) the increased marketing spend on BetterHelp deteriorated the Company’s revenue, with little return for that investment; (3) despite the Company’s acknowledgment that increased advertising spend would be marginally inefficient due to market saturation, it continued to grow its advertising spend in the BetterHelp business; and (4) despite public statements that there remained “a long runway” for BetterHelp membership growth, BetterHelp’s membership stagnated and then decreased in 2023, due to market saturation, and largely due to BetterHelp’s own marketing.

*          *          *

If you purchased or otherwise acquired Teladoc stock between November 2, 2022, and February 20, 2024, both dates inclusive, and you wish to serve as lead plaintiff in this lawsuit, we encourage you to submit your information to DiCello Levitt LLP via the form on this page. 

You can also contact DiCello Levitt partner Brian O’Mara by calling (888) 287-9005 or at investors@dicellolevitt.com. 

The deadline to apply to the Court to serve as a lead plaintiff in the Teladoc lawsuit is July 16, 2024.